98555-49-8Relevant academic research and scientific papers
Heterocyclic-substituted nitrogen-containing six-membered heterocyclic derivative and preparation method and medical application thereof
-
Paragraph 0352; 0382-0384, (2021/08/14)
The invention relates to a heterocyclic-substituted nitrogen-containing six-membered heterocyclic derivative, a preparation method thereof and application of the heterocyclic-substituted nitrogen-containing six-membered heterocyclic derivative as a PD-1/PD-L1 inhibitor. Specifically, the invention discloses a compound shown as a formula (I) or a pharmaceutically acceptable salt, a deuterated compound, a stereoisomer, a solvate and a prodrug thereof, and a preparation method and application of the compounds, and the definition of each group in the formula is detailed in the description and claims.
4-Phenyl-5-Oxo-1,4,5,6,7,8,- Hexahydroquinoline Derivatives as Medicaments for the Treatment of Infertility
-
Page/Page column 23; 24, (2009/01/20)
The invention relates to a 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivative according to Formula (I), wherein the substituents are defined as in the description, or a pharmaceutically salt thereof. The compounds of this invention are potent FSH receptor activators and may be used for treating fertility disorders in e.g. controlled ovarian hyperstimulation and IVF procedures.
4-PHENYL-5-OXO-l,4,5,6,7,8-HEXAHYDROQUINOLINE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF INFERTILITY
-
Page/Page column 35; 39; 51, (2008/06/13)
The invention relates to a 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydroquinoline derivative according to Formula (I), wherein the substituents are defined as in the description, or a pharmaceutically salt thereof. The compounds of this invention are potent FSH receptor activators and may be used for treating fertility disorders in e.g. controlled ovarian hyperstimulation and IVF procedures.
